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Abstract
Background: Recently percutaneous vertebroplasty (PVP) was frequently performed for treatment of osteoporotic
vertebral fractures (VFs). It is widely accepted that new compression fractures tend to occur adjacent to the
vertebral bodies, typically within a month after PVP. To determine the risk factors among several potential
predictors for de novo VFs following PVP in patients with osteoporosis.
Methods: We retrospectively screened the clinical results of 88 patients who had been treated by PVP. Fifteen
cases were excluded due to non-union. Of the remaining 73 patients, 19 (26.0 %) later returned with pain due to a
new vertebral compression fracture. One patient with a non-adjacent fracture and 2 patients with adjacent
factures occurring 3 months later were excluded from the study. The 9 male patients were excluded to avoid
gender bias. Ultimately, we divided the 61 remaining postmenopausal female patients (mean age: 78.9 years) into
the collapse group (14 patients) who had experienced adjacent vertebral collapse after PVP and the non-collapse
group (47 patients) who had not. Logistic regression analysis was performed to identify the risk factors for new
VFs after PVP.
Results: All 14 cases of adjacent VF occurred within the first month after surgery. The collapse group had
significantly advanced age, higher urinary N-terminal cross-linking telopeptide of type I collagen, and lower
lumbar and hip bone mineral density (BMD) scores as compared with the non-collapse group. The odds ratios for
age, lumbar, total hip, femoral neck, and trochanteric BMD were 4.5, 8.2, 4.5, 7.2, and 9.6, respectively. Positive
likelihood ratios suggested that age more than 85 years, lumbar BMD less than 0.700 [−2.6SD], total hip BMD less
than 0.700 [−1.8SD], neck BMD less than 0.600 [−2.1], and trochanter BMD less than 0.600 conferred an elevated
risk of adjacent VF.
Conclusions: Our study revealed that advanced age and decreased lumbar and hip BMD scores most strongly
indicated a risk of adjacent VF following PVP.
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Background
The incidence of osteoporotic fractures is increasing
yearly in Japan. As these injuries greatly diminish quality
of life (QOL) and activities of daily living in the elderly,
methods of preventing osteoporosis and osteoporotic
fractures are urgently required [1, 2]. Vertebral fractures
(VFs) have also been increasing and are now considered
to be common disorders that are especially problematic
in the elderly. In particular, osteoporotic VFs frequently
cause persistent back pain, which significantly impairs
mobility and QOL [3].
In 1987, Galibert first described a procedure employ-
ing the percutaneous injection of polymethylmethacry-
late (PMMA) into the vertebral body in patients with
vertebral angioma [4]. Soon afterwards, indications for
percutaneous vertebroplasty (PVP) spread widely to in-
clude osteoporotic vertebral compression fracture. PVP
provides increased strength and pain relief in vertebrae
weakened by osteoporosis [4]. In their review of 1000
consecutively treated vertebral compression fractures,
Layton et al. found that this technique had a high suc-
cess rate and low complication rate for cases of painful
spinal compression fractures [5].
Of the reported complications associated with PVP,
the most frequent are VFs [6]; patients successfully
treated by vertebroplasty often return with new pain
caused by a de novo vertebral body fracture. Therefore,
it is considered important to investigate the risk factors
for such compression fractures, although many have
been controversial because of limited data and a lack of
uniformity in measurement and evaluation [7].
It is widely accepted that new compression fractures
tend to occur adjacent to the vertebral bodies that were
initially treated [8], typically within a month after sur-
gery [9]. Therefore, with respect to PVP using PMMA, it
is paramount to mitigate the risk and prevent the occur-
rence of adjacent vertebral compression fractures soon
after surgery. There have been several reports on the risk
of fracture following operations for VF [8, 10]. However,
since these studies were over differing follow-up periods
and did not include such factors as bone turnover
markers, we focused exclusively on adjacent VFs mani-
festing within a month after surgery and analyzed pa-
tient characteristics, bone marker values, and bone
mineral density (BMD) scores to identify risk factors
associated with clinical outcome.
Methods
We retrospectively screened the case data of 88 consecu-
tive patients with osteoporotic vertebral compression
fracture who were treated at our institution between July
2004 and July 2012. Seventy-three cases of fresh fracture
were treated by PVP, while 15 cases were excluded due
to non-union. There were no patients with multiple
fractures during the study period. The indication for
PVP was incidental VF, regardless of radiographic verte-
bral collapse, causing significant back pain that could
not be relieved by conservative measures, such as non-
steroidal anti-inflammatory drug (NSAID) treatment. All
recruited patients could not move without unbearable
back pain. The surgeries were performed between 1 and
16 days (mean: 7.4 days) after pain onset. Contraindica-
tions included medical conditions such as bleeding dis-
order and a lack of definable vertebral collapse. No
patient had received prior treatment with bisphospho-
nates (BPs) or any other osteoporosis medication.
Surgery was performed for 73 cases of VF, and de novo
vertebral compression fractures were witnessed in 19
cases within 1 year. Among them, a non-adjacent verte-
bral compression fracture occurred in 1 patient within a
month after surgery, and 2 patients returned with adja-
cent vertebral compression fractures 3 months later.
These subjects were excluded from the study. Thus, we
encountered16 patients with osteoporotic adjacent verte-
bral compression fracture occurring within a month
after surgery. After initial screening, 70 patients (9 men
and 61 postmenopausal women; mean age: 77.2 years,
range: 56–96 years) who underwent elective PVP using
PMMA were considered for this study.
During PVP, there were 7 cases with cement leakage,
all of whom were female. PMMA leakage into soft tis-
sues and intradiscal tissues was observed in 4 and 3
patients, respectively. Whereas the former patients had
no adjacent VF, all 3 of the latter patients belonged to
the collapse group in this study. Furthermore, both leak-
age subgroups had significantly lower BMD than the
remaining cases (intradiscal L2–4 BMD: 0.521, P = 0.03
and soft tissue L2–4 BMD: 0.601, P < 0.05).
The male cases were then excluded from statistical
analyses to avoid gender bias. Among the remaining 61
female patients (mean age: 78.9 ± 7.8 years), 14 experi-
enced osteoporotic adjacent vertebral compression frac-
ture occurring within a month after surgery.
Before PVP, all patients were evaluated using plain
radiographs and magnetic resonance imaging (MRI) to
confirm fracture severity and location. The diagnosis of
VF by MRI was made when T1-weighted (T1W) images
showed low intensity signals and short τ inversion recov-
ery (STIR) revealed high intensity signals in the involved
vertebra in the sagittal plane. Two nationally certified
spinal surgeons and an experienced radiologist examined
all plain radiographs and MRI scans in this study. The
distribution of the fractured vertebrae was as follows:
T11, 14; T12, 23; L1, 16; L2, 7; and L4, 1 (Table 1). Pain
was evaluated using a visual analog scale (VAS).
PVP was performed within several days of hospitalization
for all cases. The patients were first placed in a prone
position on the operating table. Two single-plane mobile
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C-arms were positioned to confirm the anterior-posterior
and lateral views of the fractured vertebra. Local anesthesia
was administered topically and in the subcutaneous tissues,
muscular tissues, and periosteum of the targeted pedicle.
An 11-gauge bone-puncturing needle was used. PMMA
was bilaterally injected into the fractured vertebral body
with a 1-mL syringe until the cement reached the posterior
one-fourth of the body. Walking while wearing a corset
was permitted from the following day, and patients were
discharged within 7 days. The patients were monitored
using plain radiography at 1, 3, 6, and 12 months postoper-
atively. Patients who experienced new pain during the
follow-up period were brought back for additional MRI
examination of the thoracic and lumbar spine. BP treat-
ment was commenced for all patients after PVP.
De novo adjacent vertebral compression fractures were
confirmed by plain radiographs and MRI within a month
of surgery in 14 patients (i.e., the collapse group). We
compared the clinical and laboratory findings of the
collapse group with those of the 47 patients without
adjacent vertebral collapse (i.e., the non-collapse group).
VAS scores for pain taken before PVP and at 1 day,
1 month, and 3 months of follow-up were also compared
between the groups, as were bone turnover marker
values and BMD scores.
The day of admission to our facilities was that of pain
onset for almost all cases. Blood and urinary tests were
performed on the morning following hospitalization for
all subjects. We measured serum bone alkaline phos-
phatase (BAP) and urinary N-terminal cross-linking telo-
peptide of type I collagen (NTX) as markers of bone
formation and resorption, respectively. NTX levels were
measured with an enzyme-linked immunosorbent assay
(ELISA) (OSTEOMARK; Osteox International, Seattle,
WA) by SRL Inc. (Tokyo, Japan). On the first admission
day, BMD scores of the lumbar spine (L2–4) and unilat-
eral hip (total hip and trochanteric and femoral neck
sites) were determined using dual X-ray absorptiometry
(DXA) (Hologic, Waltham, MA, USA). Results were
expressed as the mean and standard deviation (SD) of
data whenever applicable. The change of VAS in each
group was assessed with paired t-test with Bonferroni
correction. Also, we performed Student’s t-test with re-
spect to the compared values of VAS between 2 groups.
Differences between the groups for bone turnover
marker values and BMD scores were assessed using
Welch’s t-test. Logistic regression analysis was per-
formed to obtain the risk ratios (odds ratio; OR).and de-
termine the predictors of vertebral collapse after PVP.
The changed OR was shown by the changes of 1 SD in
each parameter, We next calculated the sensitivity, speci-
ficity, positive likelihood ratio (LR+), and negative likeli-
hood ratio (LR-) of promising prognostic factors. These
parameters were determined to be useful in predicting
adjacent VF if the LR+ was greater than 5.0 and the LR-
was less than 0.2. Differences were considered to be sta-
tistically significant when P values were less than 0.05.
All analyses were performed using SPSS software for
Windows version 17.0 (SPSS, Chicago, IL, USA).
This study has been performed in accordance with the
ethical standards laid down in an appropriate version of
the revised 2014 Declaration of Helsinki. All patients
provided informed written consent prior to their inclu-
sion in the investigation. This study has been approved
by the ethics committee at Ina Central Hospital.
Results
De novo fractures were identified in 14 of 61 osteopor-
otic female patients (23.0 %) within the first month of
the follow-up period. The distribution of affected verte-
brae is listed in Table 1. The first and adjacent VFs oc-
curred frequently at the thoracolumbar junction. Eleven
of 14 fractures (78.6 %) occurred immediately above the
original VF after PVP, while 3 of 14 fractures (21.4 %)
were seen just below. This difference was significant (P
= 0.015, Fisher’s exact test).
After PVP, pain relief and improvement in mobility
was obtained in the short term. From postoperative
1 day to final follow-up, VAS scores significantly showed
lower values compared with preoperative scores in both
groups. However, at 1 month of follow-up, the mean
VAS score in the collapse group (6.8 ± 1.2) showed
significantly higher values in comparison with those in
the non-collapse group (2.5 ± 1.0) (P < 0.001), likely be-
cause of the occurrence of a new adjacent VF (Table 2).
The mean VAS pain score in the collapse group later
showed lower values to 3.3 ± 0.8 at final follow-up to
again become similar to that in the non-collapse group
(2.6 ± 1.2). However, the VAS score in the collapse group
showed higher values than those in the non-collapse
group (P = 0.015). In both group, at final follow-up VAS
score significantly improved compared with preoperative
scores.
Demographic comparisons between the 2 groups are
found in Table 3. Average age was significantly higher in
the collapse group (P < 0.001). Height, weight, and body
mass index (BMI) were not remarkably different. The
level of urinary NTX in the collapse group was signifi-
cantly higher than that in the non-collapse group (P =
Table 1 Fracture and adjacent fracture levels
Fracture level N Adjacent new fracture n (%) Level (n)
T11 14 5 (35.8 %) T10 (3), T12 (2)
T12 23 5 (21.7 %) T11 (4), L1 (1)
L1 16 3 (18.8 %) T12 (3)
L2 7 1 (14.3 %) L1 (1)
L4 1
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0.036) (Table 3). However, there was no significant dif-
ference in BAP levels. In the collapse group, lumbar (P
< 0.001), total hip (P = 0.001), femoral neck (P < 0.001),
and trochanter BMD (P < 0.001) scores were all signifi-
cantly lower than those in the non-collapse group
(Table 3). The results excluding the 3 cases with cement
leakage into discs were comparable (data not shown).
Logistic regression was used to determine the risk ra-
tios of variables possibly influencing vertebral collapse
after PVP (Table 4). Five risk factors (+1 SD for age, −1
SD for L2–4 BMD, and −1 SD each for total, neck, and
trochanter BMD) were found to be significant in a bin-
ary logistic model (P < 0.05). In particular, the OR of
total hip, femoral neck, and trochanteric BMD were 4.5,
7.2, and 9.6, respectively.
Table 5 shows the sensitivity (%), specificity (%), LR+,
and LR- of the above 5 risk factors implicated with de
novo adjacent vertebral collapse, as follows:
Age: LR+ was more than 5.0 until 85 years of age and
then 5.03 for 85 years and older. LR- was 0.20 or more
for age 75 and over but was less than 0.20 until age 75.
These results suggest that vertebroplasty is suitable for
patients who are less than 75 years old since the risk of
adjacent vertebral collapse appears to be low. In con-
trast, PVP may not be ideal for patients over 85 due to a
high risk of complications.
Lumbar spine BMD: LR+ was above 5.0 when L2–4
BMD was less than 0.700 (−2.6SD), implying a high risk
of adjacent VF. LR- was below 0.20 when BMD was
0.700 or more (−2.6SD), which indicated a low risk of
complications.
Total hip BMD: LR+ was above 5.0 when hip BMD
was less than 0.700 (−1.8SD), suggesting a high risk of
adjacent VF. LR- was below 0.20 when BMD was 0.800
(-0.8SD) or more, inferring a low risk of adjacent VF.
Femoral neck BMD: LR+ was above 5.0 when femoral
neck BMD was less than 0.600 (−2.1SD), indicating a
high risk of adjacent VF. LR- was below 0.20 when BMD
was 0.800 or more (+0.1SD), suggesting a low risk of
complications.
Trochanteric BMD: LR+ was above 5.0 when trochan-
teric BMD was less than 0.600, which indicated a high
risk of adjacent VF. LR- was below 0.20 when BMD was
0.700 or more, which was suggestive of a low risk of ad-
jacent VF.
Discussion
In our evaluation of predictive factors for de novo adja-
cent compression fractures following PVP, we uncovered
statistically significant relationships between an in-
creased risk of complications and the variables of age
and BMD scores. Interestingly, decreased lumbar and
hip BMD scores both indicated a high risk of adjacent
VFs. Based on our LR results, patients 85 years of age or
older with low BMD scores do not represent good surgi-
cal candidates for PVP. In contrast, those less than
Table 3 Patient characteristics and overall findings in the non-collapse and collapse groups
Non-collapse group n = 47 Collapse group n = 14 P value
Height (cm) 144.5 ± 3.8 142.6 ± 3.0 0.066
Weight (kg) 43.9 ± 5.4 42.0 ± 3.7 0.150
BMI (kg/m2) 21.0 ± 2.1 20.6 ± 1.5 0.497
Age (years) 77.0 ± 7.5 85.2 ± 5.8 <0.001*
BAP (U/L) 38.7 ± 16.3 35.1 ± 11.1 0.356
NTX (nmol BCE/mmol Cr) 60.8 ± 20.9 72.1 ± 15.6 0.036*
L2–4 BMD (g/cm2) 0.776 ± 0.101 0.620 ± 0.084 <0.001*
Total BMD (g/cm2) 0.814 ± 0.079 0.699 ± 0.103 0.001*
Neck BMD (g/cm2) 0.759 ± 0.086 0.618 ± 0.103 <0.001*
Troch BMD (g/cm2) 0.714 ± 0.096 0.574 ± 0.090 <0.001*
*Significant difference
Table 2 Mean VAS pain scores in the non-collapse and collapse groups
Non-collapse group (n = 47) Collapse group (n = 14) P-value between the 2 groups
Initial 9.7 ± 0.5 9.6 ± 0.8 P = 0.600
After 1 day 1.5 ± 0.7* 1.8 ± 1.0* P = 0.356
After 1 month 2.5 ± 1.0* 6.8 ± 1.2* P < 0.001
Final follow-up 2.6 ± 1.2* 3.3 ± 0.8* P = 0.015
Parameters were compared between the 2 groups using the Student’s t-test
*Significant difference. Compared with pre-operative VAS scores
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75 years old with higher BMD scores have a relatively
low risk of fracture, suggesting that these individuals are
suitable for PVP intervention.
Several authors have reported that the mechanism for
new fractures is a combination of the usually osteopor-
otic underlying condition and the hard cement injected
into the vertebral body [11–14]. Trout et al. described
that vertebral bodies adjacent to those treated with ver-
tebroplasty had greater than 4 times the risk of fracture
than non-adjacent vertebrae. The authors also showed
that new-onset adjacent-level fractures after PVP oc-
curred significantly sooner than non-adjacent ones [8].
Moreover, Uppin et al. revealed that many adjacent VFs
occurred within a month after PVP [15]. In our prelim-
inary subject screening, 18 of 19 new fractures (94.7 %)
had affected adjacent vertebrae, 17 of 19 fractures
(89.5 %) had occurred within a month after surgery, and
16 of 19 fractures (84 %) were both adjacent and mani-
fested within a month. Indeed, it appears critical to pre-
vent adjacent VFs in the month following PVP treatment.
We therefore focused on these parameters when analyzing
clinical factors, bone marker values, and BMD scores in
the present study.
Adjacent fractures occurred more significantly in the
upper vertebrae. In general, kyphosis occurs in thoraco-
lumbar fractures due to the collapse of the anterio-
superior vertebrae. When the regions are surgically
repositioned, defects in the upper vertebrae may become
present and cement might enter the fronto-tepomoral
regions. Nagaraja et al. recently showed that vertebro-
plasty alters the biomechanics of the spine, which in-
creases compression on adjacent vertebral bodies and
intervertebral discs, especially in severely osteoporotic
women [16]. Furthermore, in vitro studies have revealed
that cement-filled bone is 36 times stronger than spinal
cancellous bone [17]. Therefore, it is plausible that more
fractures occur in the upper vertebrae that make contact
with the solid cement after PVP.
Several risk factors have been described with respect
to adjacent VFs following vertebroplasty [7, 18–20].
Zhang et al. identified the significance of low lumbar
BMD, low BMI, and intradiscal cement leakage in de
novo fractures [7], while Ryo et al. implicated osteopor-
osis and intervertebral discal cement leakage [20]. Based
on these reports, the strongest prognostic clinical factors
appear to be lumbar BMD-related conditions and ce-
ment leakage.
Smaller volumes of cement have been shown to de-
crease the risk of newly forming VFs while maintaining
sufficient stability [16]. In the present series, PMMA was
injected into the vertebral body until the cement reached
the posterior one-fourth of the body, as indicated by an-
other group [17], or until significant leakage occurred.
We had anticipated that the amount of leakage would be
Table 5 Sensitivity, specificity, and cut-off values of factors
predictive of adjacent vertebral fracture
Parameter Sensitivity (%) Specificity (%) LR+ LR-
Age (years)
≥75 100 30 1.42 0.00
≥ 80 79 70 2.63 0.30
≥ 85 57 83 3.35 0.51
85 and over 21 96 5.03 0.82
L2–4 BMD (g/cm2)
< 0.600 [−3.5SD] 29 94 4.47 0.76
< 0.700 [−2.6SD] 86 83 5.03 0.17
< 0.800 [−1.8SD] 100 34 1.51 0.00
< 0.900 [−0.9SD] 100 11 1.11 0.00
Total BMD (g/cm2)
< 0.600 [−2.8SD] 29 100 ∞ 0.71
< 0.700 [−1.8SD] 43 98 20.1 0.58
< 0.800 [−0.8SD] 93 53 1.98 0.13
< 0.900 [+0.3SD] 100 9 1.09 0.00
Neck BMD (g/cm2)
< 0.600 [−2.1SD] 36 98 16.78 0.65
< 0.700 [−1.0SD] 71 74 2.79 0.38
< 0.800 [+0.1SD] 100 28 1.38 0.00
< 0.900 [+1.2SD] 100 6 1.06 0.00
Troch BMD (g/cm2)
<0.600 [-] 50 96 11.75 0.52
<0.700 [-] 100 51 2.04 0.00
<0.800 [-] 100 21 1.27 0.00
<0.900 [-] 100 4 1.04 0.00
Abbreviations: BMD bone mineral density, LR+ positive likelihood ratio, LR-
negative likelihood ratio. SD values were calculated according to the Japanese
Orthopaedic Diagnostic Guidelines using cut-off values based on Japanese
patients. The SD of trochanteric BMD could not be calculated since there are
no established values in Japan
∞: infinity
Table 4 Odds ratio and 95 % CI for risk of adjacent vertebral
fracture
Risk factor Odds ratio 95 % CI P value
−1SD of BMI 1.2 0.6–2.3 0.562
+1SD of age 4.5 1.9–13.0 0.001
+1SD of NTX 1.9 0.9–4.1 0.073
+1SD of BAP 0.7 0.3–1.4 0.442
−1SD of L2–4 BMD 8.2 2.9–34.4 <0.001
−1SD of total BMD 4.5 2.0–13.3 0.001
−1SD of neck BMD 7.2 2.6–28.8 <0.001
−1SD of troch BMD 9.6 3.0–51.2 0.001
Abbreviations: SD standard deviation, CI confidence intervals
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relatively small due to our careful adjustment of the
amount and distribution of cement administration.
However, 4 and 3 patients experienced soft tissue and
intradiscal leakage of PMMA, respectfully. The 7 pa-
tients in whom leakage was found had significantly
lower BMD scores than the remainder of the cohort.
This suggests that diminished BMD is also a serious risk
factor with respect to cement leakage.
Syed et al. revealed that subsequent adjacent and non-
adjacent fractures after PVP occurred at roughly equal
frequencies in disc extravasation and non-disc extravasa-
tion groups. [21]. However, considerable evidence sup-
ports that cement leakage is a primary risk factor for
new vertebral compression fractures [7, 10, 19]. As the 3
patients who experienced leakage into the disc space
were all in the collapse group, we suspected that leakage
of cement into this area influenced adjacent VF onset.
The BMD of the 4 cases of cement leakage into soft tis-
sue was also significantly lower than that of the
remaining cases. However, such leakage did not lead to
adjacent VF. Thus, it appears that cement leakage itself
does not lead to VFs; rather, increased disc stiffness after
leakage may have increased the risk of adjacent com-
pression fracture.
The cumulative incidence of VF over 10 years of
follow-up was shown to be between 5.1 and 22.2 % by
Yoshimura et al. [22]. Zhang et al. also reported that age
was a prominent risk factor in the occurrence of frac-
tures. We witnessed that the collapse group was signifi-
cantly older than the non-collapse group (Table 3).
Furthermore, the OR of adjacent fractures when age was
increased by 1SD was 4.5 (P = 0.001). Although age is a
well known risk factor for fractures, there have been few
reports on its relationship with PVP. Trout et al. stated
that 186 new VFs occurred in 86 of 432 patients
(19.9 %). In this study, 19 of 73 patients (26.0 %) experi-
enced de novo VFs, which was comparably higher. One
possible reason for this discrepancy is age; the median
age was 75.2 years in Trout’s report [8] versus 77.2 years
in ours. Nevertheless, such findings confirm that age
plays an important role in the frequency of subsequent
VFs. In the present study, the risk of fracture in women
was high at an age of more than 85 years and low for an
age of less than 75. Therefore, an increased fracture risk
should be expected in elderly women aged 85 years or
older.
It is widely known that fracture risk rises in patients
with high bone turnover [23]. Our findings revealed that
the level of urinary NTX in the collapse group was sig-
nificantly higher than that in the non-collapse group
(Table 3). However, there was no significant difference
by logistic regression analysis (P = 0.073). Serum BAP
levels were not apparently related to the incidence of
new fractures. These results resembled those of
Komemushi et al., who reported that a combination of
high levels of bone resorption markers and normal levels
of bone formation markers may be associated with an
increased risk of de novo fractures after PVP [24].
Urinary NTX values in our previously reported cohort of
osteoporotic outpatients was 62.2 on average, which had
risen to 76.7 on average in patients over 80 years of age
[25]. Taken together, it is conceivable that in accordance
with aging, the elevated values of urinary NTX may be
related to fracture risk.
According to the International Society for Clinical
Densitometry and International Osteoporosis Founda-
tion, one of the key clinical risk factors for osteoporosis
is diminished hip BMD [26]. In the present study, the
strongest risk factors for new VFs were lumbar as well
as hip BMD. Trochanteric BMD showed the highest
statistical correlation among hip BMD scores (Odds ra-
tio: 9.6). It is currently unknown why trochanteric BMD
might prognosticate VFs, although this may be due to
the fact that the trochanteric region involves far more
cancellous bone than cortical bone. The high risk values
of BMD based on LR+ were less than −2.6SD for lumbar,
less than −1.8SD for total hip, and less than −2.1SD for
femoral neck. The low risk values of BMD based on
LR- were −1.8SD for lumbar, less than −0.8SD for total
hip, and less than +0.1SD for femoral neck. These re-
sults indicate that an important factor in the prediction
of adjacent VFs may be hip BMD as much as lumbar
BMD. Although correlations exist between spine and hip
BMD, they are insufficient to assess the counterpart’s
BMD value [27]. Therefore, not only vertebral BMD, but
also hip BMD and especially trochanteric BMD, should
be assessed before vertebroplasty.
The main limitations of this study are its retrospective
design and relatively small sample size. However, as we
performed strict statistical analyses to compensate for
the latter shortcoming, we consider our findings to be
applicable in the treatment of spinal fractures using
PVP.
The merit of vertebroplasty is still controversial. Lind-
say et al. reported that while some clinicians felt verteb-
roplasty was an effective procedure in select patients,
others believed that other treatment modalities for
osteoporotic compression fractures were preferable to
surgery [28]. We earlier treated such cases conservatively
with rest. Patients required 3 weeks on average to regain
mobility following a reduction in pain [29]. Meanwhile,
PVP has few complications and can improve pain very
quickly, and thus represents an effective, low invasive
option. However, the occurrence of adjacent fractures re-
mains a pressing issue. We propose that not only technical
surgical improvements, such as the amount of injected
cement, but also preoperative risk evaluation for new
adjacent fractures along with postoperative treatment with
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teriparatide and other biologics, may enhance the merits
of PVP.
Conclusion
Not only lumbar, but also hip, BMD scores strongly re-
flect a risk of adjacent VF following PVP. As patients
over 85 years of age with low BMD scores showed the
highest risk of the fracture, PVP may be contraindicated
in such individuals. In contrast, we uncovered a good
surgical indication in patients less than 75 years old and
having high BMD scores.
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